Tumor necrosis factor in Plasmodium falciparum malaria: High plasma level is associated with fever, but high production capacity is associated with rapid fever clearance

European Cytokine Network

Volumn 8, Issue 1, 1997, Pages 29-35

  Mordmuller B G ^a,b,c   Metzger, W G ^a   Juillard, P ^d   Brinkman, B M N ^e   Verweij, C L ^e   Grau, G E ^d   Kremsner, P G ^a,c  

^a Albert Schweilzer Hospital   (Gabon)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Falciparum malaria; Fever; TNF; TNF polymorphism

Indexed keywords

CHLOROQUINE; CLINDAMYCIN; GAMMA INTERFERON; GLUCOSE; INTERLEUKIN 10; PHYTOHEMAGGLUTININ; PYRIMETHAMINE; QUININE; SULFADOXINE; TUMOR NECROSIS FACTOR;

ARTICLE; BLOOD LEVEL; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FEVER; GLUCOSE BLOOD LEVEL; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NECROSIS;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

EID: 0030890676     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Grau G E, Fajardo L F, Piguet P-F, Allet B, Lambert P-H, Vassalli P. 1987. Tumor necrosis factor cachectin) as an essential mediator in inurine cerebral malaria. Science 237: 1210.
2. Aggarwal B B, Natarajan K. 1996. Tumor necrosis factor: developments during the last decade. Eur Cytoline Netw. 7: 93.
3. Tracey K J, Beutler B, Lowry S F, Merryweather J, Wolpe S, Milsark I W, Hariri R J, Fahey III T J, Zentella A, Albert J D, Shires G T, Cerami A. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234:470.
4. Grau G E, Taylor T E, Molyneux M E, Wirima J J, Vassalli P, Hommel M, Lambert P-H. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 320:1586.
5. Kremsner P G, Feldmeier H, Zotter G M, Jansen-Rosseck R, Graninger W, Rocha R M, Bienzle U. 1989. Immunological alterations in uncomplicated Plasmodium falciparum malaria. Relationship between parasitaemia and indicators of macrophage activation. Acta Trop.46:351.
6. Kern P, Hemmer C J, van Damme J, Gruss H-J, Dietrich M. 1989. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 87: 139.
7. Kwiatkowski D, Hill A V S, Sambou I, Twumasi P, Castracane J, Manogue K R, Cerami A, Brewster D R, Greenwood B M. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336:1201.
8. Kwiatkowski D. 1995. Malarial toxins and the regulation of parasite density. Parasit Today. 11:206.
9. Wilson A G, di Giovine F S, Blakemore A I, Duff G W. 1992. Single base polymorphism in the human tumor necrosis factor a (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1: 353.
10. Brinkman B M N, Kaijzel E L, Huizinga T W, Giphart M J, Breedveld F C, Verweij C L. 1995. Detection of a C-insertion polymorpism within the human tumor necrosis factor α (TNF-α) gene. Hum Genet 96:449.
11. D'Alfonso S, Richiardi P M. 1994. A polmorphic variation in a putative regulation box of the TNF-α promotor region. Immnnogenetics. 39: 150.
12. Hamann A, Mantzoros C, Vidal-Puig A, Flier J S. 1995. Genetic variability in the TNF-α promotor is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun. 211:833.
13. Wildling E, Winkler S, Kremsner P G, Brandts C, Jenne L, Wernsdorfer W H. 1995. Malaria epidemiology in the province of Moyen Ogooue, Gabon. Trop Med Parasitol. 46: 77.
14. Warrell D A, Molyneux M E, Beales P F. 1990. Severe and complicated malaria. Trans R Soc Trop Med Hyg. 84, Suppl. 2:1.
15. Kremsner P G, Radloff P, Metzger W, Wildling E, Mordmüller B, Philipps J, Jenne L, Nkeyi M, Prada J, Bienzle U, Graninger W. 1995. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother. 39: 1603.
16. Metzger W, Mordmüller B, Graninger W, Bienzle U, Kremsner P G. 1995. High efficacy of short-term quinine-antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic. Antimicrob Agents Chemother. 39:245.
17. Metzger W, Mordmüller B, Graninger W, Bienzle U, Kremsner P G. 1995. Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria. J Antimicrob Chemother. 36:723.
18. Verduyn W, Doxiadis I I, Anholts J, Drabbels J J, Naipal A, d'Amaro J, Persijn G G, Giphart M J, Schreuder G M. 1993. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol. 37: 59.
19. Metzger W G, Mordmüller B G, Kremsner P G. 1995. Malaria pigment in leucocytes. Trans R Soc Trop Med Hyg. 89: 637.
20. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W. 1995. Elevated serum levels of 11-10 and IFN-γ in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol. 74:115.
21. Ho M, Sexton M M, Tongtawe P, Looaresuwan S, Suntharasamai P, Webster H K. 1995. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. J Infect Dis. 172: 838.
22. Peyron F, Burdin N, Ringwald P, Vuillez J P, Rousset F, Banchereau J. 1994. High levels of circulating IL-10 in human malaria. Clin Exp Immunol. 95: 300.
23. Deloron P, Dumont N, Nyongabo T, Aubry P, Astagneau P, Ndarugirire F, Menetrier-Caux C, Burdin N, Brelivet J C, Peyron F. 1994. Immunologic and biochemical alterations in severe falciparum malaria: relation to neurological symptoms and outcome. Clin Infect Dis. 19: 480.
24. Druilhe P, Rhodes Feuillette A, Canvier M, Peries J, Gentilini M. 1983. Production of circulating interferon in human malaria. Bull Soc Pathol Exot. 76:34.
25. Ringwald P, Peyron F, Vuillez J P, Touze J E, Le Bras J, Deloron P. 1991. Levels of cytokines in plasma during Plasmodium falciparum malaria attacks. J Clin Microbiol. 29:2076.
26. Harpaz R, Edelman R, Wasserman S S, Levine M M, Davis J R, Sztein M B. 1992. Serum cytokine profiles in experimental human malaria. J Clin Invest. 90: 515.
27. Butcher G A, Garland T, Adjukiewicz A B, Clark I A. 1990. Plasma TNF associated with malaria in patients in the Solomon islands. Trans R Soc Trop Med Hyg. 84: 658.
28. Molyneux M E, Engelmann H, Taylor T E, Wirima J J, Aderka D, Wallach D, Grau G E. 1993. Circulating plasma receptors for tumor necrosis factor in Malawian children with severe falciparum malaria. Cytokine. 5:604.
29. Kremsner P G, Winkler S, Brandts C, Wildling E, Jeune J, Graninger W, Prada J, Bienzle U, Juillard P, Grau G E. 1995. Prediction of accelerated cure in Plasinodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg. 53: 532.
30. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Warn P, Peshu N, Pasvol G, Snow R. 1995. Indicators of life-threatening malaria in African children. N Engl J Med. 332:1399.
31. While N J, Marsh K, Turner R C, Miller K D, Berry C D, Williamson D H, Brown J. 1987. Hypoglycaemia in African children with severe malaria. Lancet. 1:708.
32. Dinarello C A, Cannon J G, Wolff S M, Bernheim H A, Beutler B, Cerami A, Figari I S, Palladino M A J, O Connor J V. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin-1. J Exp Med. 163:1433.
33. De Waal Malefyt R, Abrams J, Bennet B, Figdor C G, de Vries J E. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of I1-10 produced by monocytes. J Exp Med. 174:1209.
34. Donnelly R P, Freeman S L, Hayes M P. 1995. Inhibition of 11-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J Immunol. 155: 1420.
35. Meyer C G, Kremsner P G. 1996. Malaria and onchocerciasis: On HLA and related matters. Parasit Today. 12:179.
36. McGuire W, Hill A V S, Allsopp C E M, Greenwood B M, Kwiatkowski D. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:508.
37. Stuber F, Udalova I A, Book M, Drutskaya L N, Kuprash D V, Turetskaya R L, Schade F U, Nedospasov S A. 1996. -308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promotor. J Inflamm. 46: 42.
38. Brinkman B M N, Zuijdgeest D, Kaijzel E L, Breedveld F C, Verweij C L. 1996. Relevance of the tumor necrosis factor alpha (TNF-α) -308 promotor polymorphism in the TNF-α gene regulation. J Inflamm. 46: 32.